Related Experiment Video
Updated: May 10, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Upper Respiratory Infections and Respiratory Adverse Events and Interventions in Emergency Department Sedation of
Daniel S Tsze1, Nick Barrowman2, Maala Bhatt3
1Department of Emergency Medicine, Division of Pediatric Emergency Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
Insights
Children with upper respiratory infections (URIs) undergoing emergency department (ED) sedation do not face an increased risk of respiratory adverse events or interventions. This study found no significant association between URIs and adverse respiratory outcomes in pediatric ED sedation.
Area of Science:
- Pediatric Emergency Medicine
- Anesthesiology
- Respiratory Physiology
Background:
- Children with upper respiratory infections (URIs) face higher risks during operative anesthesia and procedural sedation.
- The safety of emergency department (ED) sedation for children with URIs remains unclear.
Purpose of the Study:
- To determine if URIs increase the risk of respiratory adverse events in children undergoing ED sedation.
- To assess the association between URIs and serious respiratory interventions in pediatric ED sedation.
Main Methods:
- Secondary analysis of a prospective cohort study involving 6,292 children (≤17 years) receiving parenteral sedation in pediatric EDs.
- Multivariable regression analysis to identify associations between URIs and respiratory adverse events, serious adverse events, and interventions.
Main Results:
- Of 6,292 children, 444 (7.1%) had a URI.
- No significant increase in risk for respiratory adverse events (aOR 1.00), serious respiratory adverse events (aOR 0.53), or serious respiratory interventions (aOR 1.08) was found in children with URIs.
Conclusions:
- The presence of a URI in children undergoing ED sedation is not associated with an increased risk of respiratory adverse events.
- No increased risk for serious respiratory interventions was observed in pediatric patients with URIs receiving ED sedation.
Study Objective:
Children with upper respiratory infections (URIs) have an increased risk of respiratory adverse events when undergoing operative anesthesia and in general populations of children receiving procedural sedation. It is unclear if children with URI undergoing emergency department (ED) sedation share the same increased risk. We aimed to determine if the presence of a URI in children undergoing ED sedation is associated with increased risk of respiratory adverse events and serious respiratory interventions.
Methods:
We conducted a secondary analysis of a prospective cohort study of children aged 17 years or younger who received parenteral sedation for a painful procedure in 1 of 6 pediatric EDs. A multivariable regression model was used to identify potential associations between URI and respiratory adverse events, serious respiratory adverse events (ie, complete airway obstruction, apnea, laryngospasm, clinically apparent pulmonary aspiration, and death), and serious respiratory interventions (ie, bag-valve-mask ventilation and endotracheal intubation).
Results:
We analyzed 6,292 children; 444 (7.1%) had a URI. The risk of respiratory adverse events, serious respiratory adverse events, or serious respiratory interventions was adjusted odds ratio (aOR) 1.00 (95% confidence interval [CI] 0.78 to 1.29), 0.53 (95% CI 0.18 to 1.58), and 1.08 (95% CI 0.68 to 1.71), respectively.
Conclusion:
In this study, we found no increase in risk of any respiratory adverse events or serious respiratory interventions associated with URI in children undergoing ED sedation.
Related Concept Videos
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-IV
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Suctioning the Nasopharyngeal Airway
Equipment Required

